September #182 : More Safer Sex - by Laura Whitehorn

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Archives » POZ Magazine issues




Table of Contents
 

Features

Healing the Hurt

Hot on the Trail

From the Editor

The Not-So-Weaker Sex

Feedback

Letters- September 2012

The POZ Q+A

The Accidental Historian

What You Need to Know

Not So Sacred Bonds of Marriage

Mo Money, Mo Health

Easing the Pain of Adult Male Circumcision?

Fifty Shades of HIV?

Digital Disease Detector

We Hear You

There's No Place Like Home

POZ Survey Says

Take Good Care

What Matters to You

Clarifying HIV Heart Disease Risk

Overturning the Gay Blood Ban

Treatment News

Generic Drugs in the U.S.?

Is He or Isn’t He Cured? Real Answers to the Case of the Berlin Patient

More Safer Sex

Common Sense Rules the Court

GMHC Treatment Issues September 2012

Comfort Zone

Making Cents of Health Insurance

POZ Heroes

Midnight Cowboy

   
Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV


email print

September 2012

More Safer Sex

by Laura Whitehorn

Despite efforts to promote sex education and condom use, HIV rates are not declining. It couldn’t be clearer: We need other options to stem the tide of sexually acquired HIV cases. So it is nice to report that an experimental rectal microbicide (a gel containing HIV drugs to block HIV transmission) has been improved.

The gel, containing Viread (tenofovir), had issues associated with side effects that undercut its effectiveness as well as its tolerability in the MTN-007 trial. Researchers developed a low glycerin version of the gel, and voilà—fewer problems. Next: a trial in South Africa, Peru, Thailand and the United States to test the new gel.

Search: South Africa, Peru, Thailand, condom, rectal microbicide, Viread, tenofovir, MTN-007

Scroll down to comment on this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Hide comments

Previous Comments:


         

[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Poll
Have you ever been diagnosed with diabetes or pre-diabetes?
Yes
No

Survey
Pop Watch

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.